A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to evaluate the effect of MEDI8968 on the rate of moderate or severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in adult subjects with symptomatic, moderate to very severe COPD (Global Initiative for Chronic Obstructive Lung Disease - GOLD stage II-IV) receiving standard maintenance therapy for the underlying disease condition.
Epistemonikos ID: b9c89db926f6fa784f60e8802294075dbc1dfc1d
First added on: Jun 23, 2023